Acetylsalicylic acid seems to diminish teratogenic effects of 5-azacytidine

Periodicum Biologorum

Volumn 103, Issue 4, 2001, Pages 343-346

  Vlahović, Maja ^a   Sinčić, Nino ^a   Bulić Jakuš, Floriana ^a   Šerman, Ljiliana ^a   Šerman, Draško ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Acetylsalicyclic acid; s azacytidine; Teratogenecity

Indexed keywords

ACETYLSALICYLIC ACID; AZACITIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FETUS; FETUS GROWTH; FETUS MALFORMATION; NONHUMAN; RAT; TERATOGENICITY; TREATMENT OUTCOME;

EID: 0035723652     PISSN: 00315362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: Evidence for prostaglandin H synthase-catalyses bioactivation of thalidomide to a teratogenic reactive intermediate
2. CpG-rich islands and the function of DNA methylation
3. Teratogenic effects of the demethylating agent 5-aza-2′-deoxycytidine in the Swiss webster mouse
4. DNA methylation and polyamines in embryonic development and cancer
5. Differential staining of cartilage and bone in fetal mouse skeleton by Alcian Blue and Alizarin Red S
6. 2-Deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia
7. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxigenase-2) by aspirin
8. Targeted mutation of DNA methyltransferase gene results in embryonic lethality
9. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
10. Evidence for embryonic peroxidase-catalysed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: Modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture
11. Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications
12. Changes in the placenta and in the rat embryo caused by the demthylating agent 5-azacytidine
13. Dihidro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity
14. Biochemical toxicology of chemical teratogenesis
15. Evidence for embryonic prostaglandin H synthase-catalysed bioactivation and reactive oxygen species-mediated oxidation of macromolecules in phenytoin and benzo(a)pyrene teratogensis